ranitidine Articles
EUROPEAN STOCK COMMENT
17 January 1994
LIKELY IMPACT ON DRUG FIRMS OF ITALIAN REFORMS
17 January 1994
EUROPE STOCK COMMENT
10 January 1994
GLAXO INFRINGEMENT FILING ON RANITIDINE
10 January 1994
ARGENTINE SENATE GROUP AGAINST PATENTS BILL
10 January 1994
SANKYO-DEVELOPED DRUGS SPUR GROWTH
10 January 1994
GLAXO/WARNER-LAMBERT DEAL SIGNED
20 December 1993
DIVERSIFICATION NOT THE PATH FOR GLAXO
13 December 1993
WORLD MARKETS FOR CNS AND GASTROINTESTINALS
13 December 1993
ALTANA PLANS DRUG INNOVATION OFFENSIVE
13 December 1993
CENTRA PLANNING 1994 FAMOTIDINE SWITCH
6 December 1993
EUROPEAN STOCK COMMENT
6 December 1993
GLAXO REAFFIRMS COMMITMENT TO R&D
6 December 1993
SMITHKLINE BEECHAM GIVING TAGAMET REBATES
15 November 1993
WELLCOME RESULTS AS EXPECTED BUT US SLOWER
1 November 1993
GENERIC CIMETIDINE WINS US APPROVAL
1 November 1993
GLAXO SAYS THREE YRS FOR OTC TO PAY
25 October 1993
NOVOPHARM TO APPEAL
4 October 1993
ULCER DRUG MARKET DECLINE FORECAST
4 October 1993
EUROPEAN STOCK COMMENT
27 September 1993
US COURT UPHOLD GLAXO ZANTAC PATENT
27 September 1993
GLAXO RESULTS PLEASE, BUT CONCERNS PERSIST
20 September 1993
OMEPRAZOLE ON QUEBEC'S LIMITED LIST
13 September 1993
STRONG PERFORMANCE FROM GLAXO, AND ZANTAC
13 September 1993
US DRUGSTORE AUDIT DATA FOR JULY
6 September 1993
US ZOFRAN APPROVAL LIFTS GLAXO SHARES
23 August 1993
GLAXO MOTION TO STOP NOVOPHARM CASE DENIED
23 August 1993
EUROPEAN STOCK COMMENT
9 August 1993
GLAXO/NOVOPHARM TRIAL OVER ZANTAC PATENT
9 August 1993
WARNER-LAMBERT OTC DEALS ON ZOVIRAX, ZANTAC
2 August 1993
MISOPROSTOL PRAISED AT ILAR
26 July 1993
GASTROENTEROLOGY CONFERENCE REPORT
26 July 1993
EUROPEAN STOCK COMMENT
26 July 1993
TAGAMET A STEP NEARER TO OTC APPROVAL
12 July 1993
ZANTAC COURT RULING
12 July 1993
WILL THERE BE MORE FLEXIBILITY AT GLAXO UNDER SYKES?
28 June 1993
INDIA: A PATENT REGIME FOR DRUG SECURITY
21 June 1993
FEVER WITH RANITIDINE
14 June 1993
EUROPEAN STOCK COMMENT
31 May 1993
OTC GASTROINTESTINALS IN THE USA
24 May 1993
ADAPTING TO HEALTH CARE REFORM THE SB WAY
17 May 1993
GLAXO APPEALS OVER MEDICAID RULING
10 May 1993
OTC PROSPECTS IN FAST-GROWING KOREA
10 May 1993
GLAXO COMPROMISES OVER ONDANSETRON PATENT
26 April 1993
EUROPE STOCK COMMENT
19 April 1993
STUDY ON H2 ANTAGONISTS AND ALCOHOL
12 April 1993
PRICE FLEXIBILITY AND THE DRUG INDUSTRY
12 April 1993
EUROPE STOCK COMMENT
5 April 1993
GLAXO BENDS TO FDA MISLEADING ADS REQUIREMENT
5 April 1993
SWEDEN'S PHARMA MARKET IN 1992
5 April 1993
GLAXO CRTITICIZED
29 March 1993
EUROPE STOCK COMMENT
29 March 1993
EUROPE STOCK COMMENT
22 March 1993
SHOCK RESIGNATION OF GLAXO'S ERNEST MARIO
15 March 1993
EUROPE STOCK COMMENT
15 March 1993
GLAXO RESULTS GOOD, BUT RISKS STILL EVIDENT
1 March 1993
GLOBAL SALES OF H2 BLOCKERS TO DECLINE?
1 March 1993
EUROPE STOCK COMMENT
22 February 1993
GLAXO INTERIM PROFITS UP 16%
22 February 1993
ULCER STUDY NO THREAT TO ULCER DRUG FIRMS
22 February 1993
EUROPE STOCK COMMENT
1 February 1993
GLAXO TO FILE FOR OTC ZANTAC IN 1994?
1 February 1993
GLAXO CASH CALL, BUYING RUMORS
25 January 1993
LONG-TERM USE OF CISAPRIDE IN UK
18 January 1993
GLAXO AND LILLY'S ULCER DRUGS OFF MEDI-CAL
18 January 1993
GLOBAL DRUG MARKET: 30 YEARS OF GROWTH
4 January 1993
GLAXO'S IMITREX GETS FDA BACKING IN USA
14 December 1992
GASTROINTESTINAL MARKET REVIEW
7 December 1992
US/CANADA DRUG PRICE STUDY "MISLEADING"
2 November 1992
RPSGB CANDIDATES FOR POM-TO-P SWITCHING
2 November 1992
ANTI-ULCER DRUG MARKET
5 October 1992
SIDE EFFECTS WITH OMEPRAZOLE?
7 September 1992
GLAXO PROSPECTS GLOOM: FACT OR FICTION?
3 August 1992
Glaxo recieves Zantax extension
8 June 1992
ZANTAC TOPS MAIL ORDER SALES IN USA
8 June 1992
GLAXO FACTORY IN SAUDI ARABIA
1 June 1992
H PYLORI TREATMENT: A ROLE FOR OMEPRAZOLE?
25 May 1992
STOCK MARKET COMMENTARY: EUROPE
25 May 1992
STOCK MARKET COMMENTARY: EUROPE
18 May 1992
STUDY SUPPORTS ULCER/H PYLORI HYPOTHESIS
11 May 1992
SWEDEN'S PHARMA MARKET IN 1991
11 May 1992
THE UK DRUG INDUSTRYIN REVIEW: 1961-1991
4 May 1992
US NEW PRESCRIPTI0N DRUG SALES IN 1991
13 April 1992
MAINTENANCE ULCER THERAPY CUT URGED
6 April 1992
MAINTENANCE ULCER THERAPY CUT URGED
6 April 1992
US PRESCRIPTION PRICES UP 8.1%IN 1991
23 March 1992
GLAXO CHIEF ON PHARMA INDUSTRY, PUBLIC NEEDS
16 March 1992
US GENERIC DRUG MARKET TO 1995
17 February 1992
US OTC DRUGMAKERS A TAKEOVER TARGET
17 February 1992
FIRST LAUNCH OF LANSOPRAZOLE
20 January 1992
STOCK MARKET COMMENTARY: EUROPE
13 January 1992
ULCER DRUGS & ALCOHOL
6 January 1992
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
